National Trends in Utilization and Expenditures for Plastic Surgery From 2002 to 2022: A Cross‐Sectional Study
Health Science Reports · 2026-10 · 9 (10)
DOI: 10.1002/hsr2.73071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 06.10.2026. Verfasst von Jason Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Shifting patterns in the financing of plastic surgery are not fully understood. We analyze payer trends for office and outpatient plastic surgery visits from 2002 to 2022.
Methods
We investigated office‐based and hospital outpatient department plastic surgery visits in the Medical Expenditure Panel Survey, a national dataset of healthcare usage and expenditures. During the study period (2002–2022), we calculated the yearly median amount of money charged and paid per visit, the distribution of payer type expenditures, and the mean payment‐to‐charge ratio per visit. Dollar amounts were inflation‐adjusted to 2022 estimates.
Results
From 2002 to 2022, there were 5824 office‐based plastic surgery visits and 850 outpatient department plastic surgery visits, representing 71,597,980 and 10,589,575 total visits, respectively. For office‐based visits, the number of visits declined across the study period from 3,982,280 to 1,418,032 (−64.4%), the median (IQR) payment per visit increased from $119.06 ($188.49) to $263.48 ($721.35) (+121.3%), and the median (IQR) payment‐to‐charge ratio decreased from 0.71 (0.43) to 0.47 (0.45) (−33.8%). Payments were primarily private insurance (37.6%) and out‐of‐pocket (36.0%). For outpatient department visits, the median (IQR) payment‐to‐charge ratio also decreased significantly from 0.56 (0.44) to 0.35 (0.45) (−37.1%); median (IQR) payment per visit was $1587.93 ($1287.80) without significant changes over time. Most expenditures were from private insurance (58.5%), then self‐pay (17.8%), and Medicare (11.7%).
Conclusion
National trends in plastic surgery expenditures show decreasing payment‐to‐charge ratios for both office and outpatient department settings. However, the payer mix driving these trends differs by practice setting. Limitations of the study include survey‐based data, a small sample size, and the exploratory nature of the study with limited statistical analysis. Further research is warranted to uncover factors that may account for these findings and their implications.
Autor:innen und Institutionen
- Division of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.
ORCID-Profile: Jason Zhang, Anitesh Bajaj, Timothy Burke, Matthew D Ramsey, Hannah Soltani, Chad M Teven
Zitieren
APA
Zhang, J., Bajaj, A., Shah, S. A., Nenchev, K., Burke, T., Ramsey, M. D., Soltani, H., Howard, M. A., & Teven, C. M. (2026). National Trends in Utilization and Expenditures for Plastic Surgery From 2002 to 2022: A Cross‐Sectional Study. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73071
Vancouver
Zhang J, Bajaj A, Shah SA, Nenchev K, Burke T, Ramsey MD, et al. National Trends in Utilization and Expenditures for Plastic Surgery From 2002 to 2022: A Cross‐Sectional Study. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73071
BibTeX
@article{Zhang2026,
author = {Zhang, Jason and Bajaj, Anitesh and Shah, Shivani A and Nenchev, Kristian and Burke, Timothy and Ramsey, Matthew D and Soltani, Hannah and Howard, Michael A and Teven, Chad M},
title = {National Trends in Utilization and Expenditures for Plastic Surgery From 2002 to 2022: A Cross‐Sectional Study},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/hsr2.73071}
}
EUVIMED